Search
In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by MSK, Weill Cornell Medicine, and The Rockefeller University identified a vulnerability that opens the door to new treatments.
Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.
Learn about new insights into endometrial cancer discovered by MSK experts, including why the growing rates of this cancer are even more dangerous for Black women.
Learn why Black men should be especially mindful of prostate cancer risk.
Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo®) and ipilimumab (Yervoy®) significantly increased overall survival versus treatment with sunitinib (Sutent®) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) that were reported online today in the New England Journal of Medicine.
An FDA-approved drug used to treat leukemia can serve as a temporary off switch for CAR T cells, MSK scientists have found.
According to a new study from Memorial Sloan Kettering published June 24 in Nature Medicine, patients in active cancer treatment who develop COVID-19 infection don’t fare any worse than other hospitalized patients. Researchers say their findings suggest that no one should delay cancer treatment because of concerns about the virus.
Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.
Lea sobre una vacuna terapéutica que podría ayudar a prevenir que ciertos casos de cáncer de páncreas y colorrectal vuelvan a aparecer.
Oncologic outcomes are similar with the use of a sentinel lymph node algorithm compared to performing a full pelvic and paraaortic lymph node dissection in node-negative patients with deeply invasive endometroid endometrial carcinoma.